Vigabatrin For Oral Solution Powder, For Solution
Product Images NDC 31722-009

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Vigabatrin For Oral Solution (NDC 31722-009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 (10)

An instructional black-and-white illustration labeled Figure H showing a hand holding a syringe positioned vertically inside a glass cup. The image likely demonstrates a step in preparing or administering vigabatrin oral solution, powder for solution, 50 mg/mL by Camber Pharmaceuticals.*

FDA Label Image

11 (11)

A black-and-white illustration showing a hand holding a syringe with a graduated scale. The figure is labeled as "Figure 1" below the image. It likely demonstrates the proper way to hold or measure medication in a syringe.*

FDA Label Image

12 (12)

An illustration showing a child receiving an oral dose of medication from a syringe, demonstrating administration of an oral solution.*

FDA Label Image

17 (17)

Vigabatrin for Oral Solution USP 500 mg packet displayed beside two oral syringes, a glass of water with a spoon, and a pair of scissors. The label shows the product name, dosage strength, and labeler Camber Pharmaceuticals. The powder is for oral solution preparation.*

FDA Label Image

18 (18)

An instructional illustration showing a hand pouring a packet labeled 'vigabatrin for oral solution USP, 50 mg/mL' powder into a clear glass of water, demonstrating preparation of the oral solution for administration. The packet displays the labeler name Camber Pharmaceuticals, Inc.*

FDA Label Image

2 (2)

An instructional diagram of an oral syringe showing labeled parts including the tip, dosage indicators on the barrel, bottom of white plunger, and the plunger itself. The syringe is designed for precise measurement and administration of oral liquid medication.*

FDA Label Image

4 (4)

An illustration labeled Figure B showing two clear tall drinking glasses. One glass contains water with ice cubes floating in it, and the other glass is empty except for a single ice cube at the bottom.*

FDA Label Image

5 (5)

An instructional illustration labeled 'Figure C' showing a hand stirring a liquid in a glass using a stirring rod or similar instrument. No additional product details or text are shown in the image.*

FDA Label Image

6 (6)

An instructional illustration shows a hand holding an oral dosing syringe filled with liquid medication. The syringe features clear volume markings for accurate measurement. The image is labeled as Figure D, demonstrating correct handling of the oral dosing syringe for medication administration.*

FDA Label Image

7 (7)

An instructional illustration labeled 'Figure E' showing a hand holding a syringe with an arrow pointing to and labeling the 10 mL line on the syringe barrel.*

FDA Label Image

8 (8)

An instructional illustration labeled 'Figure F' showing a hand holding a syringe being filled with oral solution from a glass. The image demonstrates the proper technique for drawing vigabatrin oral solution for administration.*

FDA Label Image

9 (9)

An instructional illustration labeled Figure G showing a hand holding a teaspoon partially submerged in a glass of water. It appears to demonstrate mixing or measuring liquid, relevant to oral solution preparation.*

FDA Label Image

Camber (Camber)

FDA Label Image

Carton (Carton)

Packaging label for Vigabatrin for Oral Solution, USP 500 mg per packet powder for solution containing 50 packets. Manufactured by Camber Pharmaceuticals, Inc. The label includes directions to mix each packet with 10 mL of water before administration and storage instructions to keep at 20° to 25°C. The label displays NDC 31722-009-50 and contact information for medication guidance.*

FDA Label Image

Figure-1 (Figure 1)

A line graph showing the percentage reduction in seizure frequency for patients treated with different doses of vigabatrin (1 g/day, 3 g/day, and 6 g/day) compared to placebo. The x-axis represents the percentage of patients, while the y-axis represents the percentage reduction in seizure frequency, with higher values indicating improvement.*

FDA Label Image

Figure-2 (Figure 2)

A cumulative distribution plot showing the percentage reduction in seizure frequency for patients treated with 3g/day vigabatrin (VGB) compared to placebo. The x-axis represents the percentage of patients, and the y-axis shows percent reduction in seizure frequency with labels for improvement, no change, and worsening.*

FDA Label Image

Sachet (Sachet)

Vigabatrin for Oral Solution, USP 500 mg packet label from Camber Pharmaceuticals, Inc. The label shows a single-dose packet of powder for oral solution with directions to mix each packet with 10 mL of water before administration. It includes storage instructions, a pharmacist advisory, contact information, manufacturer details, and a barcode.*

FDA Label Image

Vigabatrin-structure (Vigabatrin Structure)

Chemical structure diagram of vigabatrin, showing the molecular arrangement of atoms including carbon, hydrogen, nitrogen, and oxygen.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.